Estradiol / Oestrogen (E2) Test in Moradabad

The Estradiol test is a blood test that measures the level of E2, the most potent and biologically active form of oestrogen in the human body. Estradiol is a steroid hormone produced primarily by the granulosa cells of ovarian follicles in women under the stimulation of follicle-stimulating hormone, with smaller contributions from the adrenal glands and from peripheral conversion of androgens to oestrogen in adipose tissue. In men, E2 is produced in small but physiologically important quantities by the testes and through peripheral aromatisation of testosterone in fat tissue, playing essential roles in bone health, libido, and cardiovascular function. E2 is the dominant oestrogen during the reproductive years, regulating the menstrual cycle in coordination with FSH, LH, and progesterone, driving the development and maintenance of female secondary sexual characteristics, stimulating endometrial proliferation in preparation for implantation, and exerting widespread protective effects on bone density, cardiovascular health, skin, and cognitive function. E2 levels fluctuate dramatically across the menstrual cycle, rising progressively during the follicular phase as the dominant follicle matures, surging sharply at mid-cycle to trigger the LH surge and ovulation, and then declining during the luteal phase before falling to their lowest levels at menstruation. In India, conditions associated with E2 dysregulation including polycystic ovary syndrome, premature ovarian insufficiency, infertility, perimenopause, and endocrine disruption from environmental oestrogens are increasingly prevalent, making E2 measurement a routinely essential investigation in gynaecological, reproductive, and endocrinological practice. The test is performed on a small blood sample drawn from a vein and completed in under five minutes.

Doctors prescribe an E2 test in the following situations: Evaluating menstrual irregularities and amenorrhoea in women with absent, infrequent, or irregular periods where E2 measurement alongside FSH and LH characterises the hormonal basis of menstrual dysfunction, distinguishing between ovarian, pituitary, and hypothalamic causes that require fundamentally different treatment approaches. Investigating infertility in women where baseline E2 on day two or three of the menstrual cycle assesses ovarian reserve and follicular status, guides ovarian stimulation protocols in assisted reproduction, and monitors follicular development during IVF cycles to optimise trigger timing and oocyte retrieval. Diagnosing premature ovarian insufficiency in women under 40 with amenorrhoea and menopausal symptoms where a low E2 alongside elevated FSH confirms ovarian failure, with significant implications for long-term bone health, cardiovascular risk, and the urgent need for hormone replacement therapy. Assessing menopausal status and guiding hormone replacement therapy in perimenopausal and postmenopausal women where E2 measurement quantifies the degree of oestrogen deficiency, helps determine HRT candidacy, and monitors therapeutic oestrogen levels during treatment to ensure efficacy and safety. Evaluating gynaecomastia in men where elevated E2 from increased peripheral aromatisation of testosterone, testicular oestrogen-secreting tumours, or exogenous oestrogen exposure causes breast tissue development, and where E2 measurement guides the diagnostic workup and treatment planning. Monitoring ovarian stimulation during assisted reproductive technology cycles where serial E2 measurements track follicular development, guide gonadotropin dose adjustments, predict response to the ovulation trigger, and assess the risk of ovarian hyperstimulation syndrome before oocyte retrieval.

The E2 test measures the concentration of estradiol in the blood serum, expressed in picograms per millilitre (pg/mL) or picomoles per litre (pmol/L). Reference ranges vary significantly by gender, menstrual cycle phase, and menopausal status, making clinical context essential for accurate result interpretation. Normal ranges are 30 to 400 pg/mL in premenopausal women depending on cycle phase, with a mid-cycle peak of 150 to 750 pg/mL at ovulation, less than 30 pg/mL in postmenopausal women, and 10 to 40 pg/mL in adult men. Normal for Phase and Gender A result within the expected range for the specific cycle phase, menopausal status, or gender at the time of testing indicates appropriate E2 production. In women undergoing ovarian stimulation for IVF, E2 levels are interpreted in the context of the number and size of developing follicles rather than absolute reference ranges, with each mature follicle expected to contribute approximately 150 to 200 pg/mL to the total E2 level. Low E2 A low E2 result indicates insufficient oestrogen production and may be seen in premature ovarian insufficiency, hypothalamic amenorrhoea from excessive exercise or low body weight, hyperpituitarism with FSH or LH deficiency, menopause, and in women on GnRH agonist therapy for endometriosis or uterine fibroids. In postmenopausal women, persistently very low E2 is associated with accelerated bone loss, cardiovascular risk, urogenital atrophy, and cognitive changes requiring clinical attention and possible HRT. Elevated E2 An elevated E2 result may indicate ovarian hyperstimulation during fertility treatment, oestrogen-secreting ovarian tumours, exogenous oestrogen intake, advanced liver disease with impaired oestrogen metabolism, or obesity-related increased peripheral aromatisation. In men, elevated E2 is associated with gynaecomastia, reduced libido, erectile dysfunction, and suppression of testosterone production through negative feedback on the hypothalamic-pituitary axis.

The timing of the E2 test relative to the menstrual cycle is critically important, as estradiol levels vary enormously across cycle phases and results cannot be accurately interpreted without knowing the precise day of the cycle on which the sample was collected. For baseline ovarian reserve assessment and IVF protocol planning, E2 is measured on day two or three of the menstrual cycle. For ovulation confirmation and mid-cycle monitoring, testing is timed around cycle day 12 to 14. Always inform your doctor of the exact cycle day at the time of testing. No fasting is required for the E2 test as food intake does not significantly affect estradiol concentrations. However, since E2 is routinely ordered alongside FSH, LH, prolactin, and AMH as part of a hormonal panel, morning collection is preferred to standardise conditions and ensure all co-ordered parameters are collected under consistent timing conditions for reliable combined interpretation. Inform your doctor about all hormonal medications currently being taken, including oral contraceptives, hormone replacement therapy, clomiphene, gonadotropin injections, GnRH agonists or antagonists, and aromatase inhibitors, as these directly and significantly alter E2 levels and are essential context for accurate result interpretation. If you are undergoing serial E2 monitoring during an IVF cycle, consistent timing of blood collection and use of the same laboratory assay platform across monitoring visits ensures reliable trend comparison to guide treatment decisions. Staying well hydrated before the blood draw facilitates easier venous access and a smooth collection experience.

If you are booking through the SecondMedic platform the Estradiol E2 test price in Moradabad can cost you around Rs. 620. You may also consider booking a comprehensive female hormonal panel that includes E2 alongside FSH, LH, prolactin, AMH, and progesterone for a complete assessment of ovarian function and reproductive hormonal health at a bundled price on SecondMedic.

SecondMedic offers convenient home sample collection for the E2 test in Moradabad, making it easy to get tested without visiting a diagnostic centre. Home collection is available free of charge for orders above Rs. 300. A trained phlebotomist will visit your preferred address between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Your blood sample is processed at NABL-accredited partner laboratories, and your report is delivered within 24 hours directly to your WhatsApp and email.